Dimensional Fund Advisors LP Has $74.62 Million Stock Holdings in Novanta Inc. $NOVT

Dimensional Fund Advisors LP increased its position in shares of Novanta Inc. (NASDAQ:NOVT) by 5.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 631,806 shares of the technology company’s stock after acquiring an additional 33,885 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Novanta were worth $74,616,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC increased its stake in Novanta by 27.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,776,694 shares of the technology company’s stock valued at $210,307,000 after purchasing an additional 377,232 shares in the last quarter. Conestoga Capital Advisors LLC boosted its position in shares of Novanta by 3.4% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,458,259 shares of the technology company’s stock worth $173,518,000 after purchasing an additional 47,540 shares in the last quarter. State Street Corp grew its holdings in shares of Novanta by 1.0% in the 4th quarter. State Street Corp now owns 1,319,474 shares of the technology company’s stock valued at $157,004,000 after buying an additional 13,603 shares during the period. Wasatch Advisors LP grew its holdings in shares of Novanta by 10.6% in the 2nd quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company’s stock valued at $141,827,000 after buying an additional 104,985 shares during the period. Finally, Bamco Inc. NY increased its position in shares of Novanta by 49.4% in the 4th quarter. Bamco Inc. NY now owns 936,962 shares of the technology company’s stock valued at $111,489,000 after buying an additional 309,869 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Stock Up 2.6%

Novanta stock opened at $142.55 on Friday. The company has a 50 day moving average of $154.33 and a 200-day moving average of $140.67. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $171.85. The stock has a market capitalization of $5.38 billion, a PE ratio of 103.30 and a beta of 1.67.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.03. The business had revenue of $257.71 million for the quarter, compared to analyst estimates of $253.40 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the business posted $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, equities research analysts anticipate that Novanta Inc. will post 3.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

NOVT has been the topic of several research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Novanta in a research note on Wednesday, July 15th. Robert W. Baird set a $180.00 price target on Novanta in a report on Tuesday, June 9th. Finally, Wall Street Zen lowered Novanta from a “buy” rating to a “hold” rating in a research report on Saturday. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $180.00.

Insider Transactions at Novanta

In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the completion of the transaction, the chief executive officer owned 42,761 shares in the company, valued at approximately $6,432,537.23. This represents a 14.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.20% of the company’s stock.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.